86 related articles for article (PubMed ID: 18367633)
1. Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells.
Bondioni S; Angioni AR; Corbetta S; Locatelli M; Ferrero S; Ferrante E; Mantovani G; Olgiati L; Beck-Peccoz P; Spada A; Lania AG
Exp Biol Med (Maywood); 2008 Apr; 233(4):439-46. PubMed ID: 18367633
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas.
Renner U; Arzberger T; Pagotto U; Leimgruber S; Uhl E; Müller A; Lange M; Weindl A; Stalla GK
J Clin Endocrinol Metab; 1998 Apr; 83(4):1368-75. PubMed ID: 9543168
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas.
Saveanu A; Gunz G; Guillen S; Dufour H; Culler MD; Jaquet P
Neuroendocrinology; 2006; 83(3-4):258-63. PubMed ID: 17047391
[TBL] [Abstract][Full Text] [Related]
4. Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.
Peverelli E; Mantovani G; Vitali E; Elli FM; Olgiati L; Ferrero S; Laws ER; Della Mina P; Villa A; Beck-Peccoz P; Spada A; Lania AG
J Clin Endocrinol Metab; 2012 Mar; 97(3):967-77. PubMed ID: 22259062
[TBL] [Abstract][Full Text] [Related]
5. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2013 May; 154(5):1711-21. PubMed ID: 23539512
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
Li Q; Su Z; Liu J; Cai L; Lu J; Lin S; Xiong Z; Li W; Zheng W; Wu J; Zhuge Q; Wu Z
Mol Cell Endocrinol; 2014 Jan; 382(1):377-384. PubMed ID: 24184771
[TBL] [Abstract][Full Text] [Related]
7. Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation.
Occhi G; Regazzo D; Albiger NM; Ceccato F; Ferasin S; Scanarini M; Denaro L; Cosma C; Plebani M; Cassarino MF; Mantovani G; Stalla GK; Pecori Giraldi F; Paez-Pareda M; Scaroni C
Endocrinology; 2014 Sep; 155(9):3538-49. PubMed ID: 24926820
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
9. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
10. The thyrotrope-restricted isoform of the retinoid-X receptor-gamma1 mediates 9-cis-retinoic acid suppression of thyrotropin-beta promoter activity.
Haugen BR; Brown NS; Wood WM; Gordon DF; Ridgway EC
Mol Endocrinol; 1997 Apr; 11(4):481-9. PubMed ID: 9092800
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor gene expression in human adenohypophysial adenomas.
Stefaneanu L; Kovacs K; Horvath E; Buchfelder M; Fahlbusch R; Lancranjan L
Endocrine; 2001 Apr; 14(3):329-36. PubMed ID: 11444429
[TBL] [Abstract][Full Text] [Related]
12. The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy.
Wang Y; Li J; Tohti M; Hu Y; Wang S; Li W; Lu Z; Ma C
J Exp Clin Cancer Res; 2014 Jul; 33(1):56. PubMed ID: 25027022
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
14. Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.
Gabalec F; Beranek M; Netuka D; Masopust V; Nahlovsky J; Cesak T; Marek J; Cap J
Pituitary; 2012 Jun; 15(2):222-6. PubMed ID: 21597974
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor.
Radl DB; Ferraris J; Boti V; Seilicovich A; Sarkar DK; Pisera D
PLoS One; 2011 Mar; 6(3):e18097. PubMed ID: 21464994
[TBL] [Abstract][Full Text] [Related]
16. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
[TBL] [Abstract][Full Text] [Related]
17. Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas.
Gao Z; Cai L; Lu J; Wang C; Li Q; Chen J; Song X; Chen X; Zhang L; Zheng W; Su Z
Med Sci Monit; 2017 Apr; 23():1827-1833. PubMed ID: 28411401
[TBL] [Abstract][Full Text] [Related]
18. Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.
Su Z; Wang C; Wu J; Jiang X; Chen Y; Chen Y; Zheng W; Zhuge Q; Wu Z; Zeng Y
Neurol Sci; 2012 Apr; 33(2):275-9. PubMed ID: 21748460
[TBL] [Abstract][Full Text] [Related]
19. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family.
Samad TA; Krezel W; Chambon P; Borrelli E
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14349-54. PubMed ID: 9405615
[TBL] [Abstract][Full Text] [Related]
20. Truncated RAR beta isoform enhances proliferation and retinoid resistance.
Swift ME; Wallden B; Wayner EA; Swisshelm K
J Cell Physiol; 2006 Dec; 209(3):718-25. PubMed ID: 17001699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
